Loading…
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE
Wang, Xiaoxin X, Levi, Jonathan, Luo, Yuhuan, Myakala, Komuraiah, Herman-Edelstein, Michal, Qiu, Liru, Wang, Dong, Peng, Yingqiong, Grenz, Almut, Lucia, Scott, Dobrinskikh, Evgenia, D'Agati, Vivette D, Koepsell, Hermann, Kopp, Jeffrey B, Rosenberg, Avi Z, Levi, Moshe
Published in The Journal of biological chemistry (31.03.2017)
Published in The Journal of biological chemistry (31.03.2017)
Get full text
Journal Article
Loading…
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Michel, Martin C., Foster, Carolyn, Brunner, Hans R., Liu, Lisheng
Published in Pharmacological reviews (01.04.2013)
Published in Pharmacological reviews (01.04.2013)
Get full text
Journal Article
Loading…
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
Liu, Hongyan, Sridhar, Vikas S., Boulet, Jacinthe, Dharia, Atit, Khan, Abid, Lawler, Patrick R., Cherney, David Z.I.
Published in Metabolism, clinical and experimental (01.01.2022)
Published in Metabolism, clinical and experimental (01.01.2022)
Get full text
Journal Article
Loading…
Loading…
Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease
Falkevall, Annelie, Mehlem, Annika, Palombo, Isolde, Heller Sahlgren, Benjamin, Ebarasi, Lwaki, He, Liqun, Ytterberg, A. Jimmy, Olauson, Hannes, Axelsson, Jonas, Sundelin, Birgitta, Patrakka, Jaakko, Scotney, Pierre, Nash, Andrew, Eriksson, Ulf
Published in Cell metabolism (07.03.2017)
Published in Cell metabolism (07.03.2017)
Get full text
Journal Article
Loading…
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Natale, Patrizia, Palmer, Suetonia C, Navaneethan, Sankar D, Craig, Jonathan C, Strippoli, Giovanni Fm
Published in Cochrane database of systematic reviews (29.04.2024)
Published in Cochrane database of systematic reviews (29.04.2024)
Get more information
Journal Article
Loading…
Loading…
Loading…
Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
Eller, Kathrin, Kirsch, Alexander, Wolf, Anna M., Sopper, Sieghart, Tagwerker, Andrea, Stanzl, Ursula, Wolf, Dominik, Patsch, Wolfgang, Rosenkranz, Alexander R., Eller, Philipp
Published in Diabetes (New York, N.Y.) (01.11.2011)
Published in Diabetes (New York, N.Y.) (01.11.2011)
Get full text
Journal Article
Loading…
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
Kodera, R, Shikata, K, Kataoka, H. U, Takatsuka, T, Miyamoto, S, Sasaki, M, Kajitani, N, Nishishita, S, Sarai, K, Hirota, D, Sato, C, Ogawa, D, Makino, H
Published in Diabetologia (01.04.2011)
Published in Diabetologia (01.04.2011)
Get full text
Journal Article
Loading…
Loading…
Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
Weil, E. Jennifer, Fufaa, Gudeta, Jones, Lois I., Lovato, Tracy, Lemley, Kevin V., Hanson, Robert L., Knowler, William C., Bennett, Peter H., Yee, Berne, Myers, Bryan D., Nelson, Robert G.
Published in Diabetes (New York, N.Y.) (01.09.2013)
Published in Diabetes (New York, N.Y.) (01.09.2013)
Get full text
Journal Article
Loading…
Vitamin D inhibits ferroptosis and mitigates the kidney injury of prediabetic mice by activating the Klotho/p53 signaling pathway
Chen, Hao, Zhang, Yujing, Miao, Yufan, Song, Hanlu, Tang, Lulu, Liu, Wenyi, Li, Wenjie, Miao, Jinxin, Li, Xing
Published in Apoptosis (London) (01.10.2024)
Published in Apoptosis (London) (01.10.2024)
Get full text
Journal Article
Loading…
Loading…
Loading…
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Miao, Yan, Ottenbros, Stefan A., Laverman, Goos D., Brenner, Barry M., Cooper, Mark E., Parving, Hans-Henrik, Grobbee, Diederick E., Shahinfar, Shahnaz, de Zeeuw, Dick, Lambers Heerspink, Hiddo J.
Published in Hypertension (Dallas, Tex. 1979) (01.07.2011)
Published in Hypertension (Dallas, Tex. 1979) (01.07.2011)
Get full text
Journal Article
Loading…
Loading…
Ketogenic diets and β-hydroxybutyrate in the prevention and treatment of diabetic kidney disease: current progress and future perspectives
Li, Junle, He, Wanhong, Wu, Qianshi, Qin, Yuanyuan, Luo, Changfang, Dai, Zhuojun, Long, Yang, Yan, Pijun, Huang, Wei, Cao, Ling
Published in BMC nephrology (07.03.2025)
Published in BMC nephrology (07.03.2025)
Get full text
Journal Article
Loading…
Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial
Tonneijck, Lennart, Muskiet, Marcel H. A., Smits, Mark M., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Published in Diabetes, obesity & metabolism (01.12.2017)
Published in Diabetes, obesity & metabolism (01.12.2017)
Get full text
Journal Article
Loading…
Altered Brain Dynamics in Patients With Type 1 Diabetes During Working Memory Processing
Embury, Christine M., Wiesman, Alex I., Proskovec, Amy L., Heinrichs-Graham, Elizabeth, McDermott, Timothy J., Lord, Grace H., Brau, Kaitlin L., Drincic, Andjela T., Desouza, Cyrus V., Wilson, Tony W.
Published in Diabetes (New York, N.Y.) (01.06.2018)
Published in Diabetes (New York, N.Y.) (01.06.2018)
Get full text
Journal Article